670 results on '"Patel, Parul"'
Search Results
102. Use of a simplified sample processing step without RNA extraction for direct SARS-CoV-2 RT-PCR detection
103. Multi-modality imaging findings of disseminated juvenile xanthogranuloma with renal involvement in an infant
104. Facilitating pharmacokinetic studies in children: a new use of dried blood spots
105. Large-area soil moisture estimation using multi-incidence-angle RADARSAT-1 SAR data
106. Multicompartmental pharmacokinetic evaluation of long‐acting cabotegravir in healthy adults for HIV preexposure prophylaxis.
107. Multiparametric magnetic resonance imaging to characterize cabotegravir long‐acting formulation depot kinetics in healthy adult volunteers.
108. Pharmacokinetics of Single-Dose Dolutegravir in HIV-Seronegative Subjects With Moderate Hepatic Impairment Compared to Healthy Matched Controls
109. Evidence of oligonucleotides containing 8-hydroxy-2′-deoxyguanosine in human urine
110. Psychometric properties of a lipodystrophy scale
111. Long-acting cabotegravir and rilpivirine dosed every 2 months in adults with HIV-1 infection (ATLAS-2M), 48-week results: a randomised, multicentre, open-label, phase 3b, non-inferiority study
112. Clonal Expansion of Mutant p53 Clones By MDM2 Inhibition in Acute Myeloid Leukemias
113. Modelling of Incoming Longwave Radiation Under Foggy Sky over Multiple Agro-Climate Settings of India
114. LB-8. Summary of COVID-Related Impact on Cabotegravir and Rilpivirine Long-Acting (CAB+RPV LA) Dosing Across the Six Ongoing Global Phase IIb and IIIb Clinical Trials
115. 1029. Long-Term Patient Adherence and Management of Treatment Interruptions With Long-Acting Injectable Cabotegravir + Rilpivirine for Maintenance Therapy in Phase IIb/III Studies
116. Quality Initiative to Reduce Catheter-Associated Urinary Tract Infections Using Cleansing Cloths With a Standardized Method
117. Effect of Intravenous Zanamivir on Cardiac Repolarization
118. Long-term follow-up of riboflavin/ultraviolet A (370 nm) corneal collagen cross-linking to halt the progression of keratoconus
119. Dried blood spots and sparse sampling: a practical approach to estimating pharmacokinetic parameters of caffeine in preterm infants
120. Peculiar Case of Hyperthyroidism in a Young Girl with Down Syndrome
121. Sonography of Invasive Lobular Carcinoma
122. Ultrasound-Guided Breast Biopsies
123. Multidrug Resistant Organisms in Supply Carts of Contact Isolation Patients
124. The Use of Rat Lens Explant Cultures to Study the Mechanism of Drug-Induced Cataractogenesis
125. A randomised, prospective study to investigate the efficacy of riboflavin/ultraviolet A (370 nm) corneal collagen cross-linkage to halt the progression of keratoconus
126. Pharmacokinetics of the HIV integrase inhibitor S/GSK1349572 co-administered with acid-reducing agents and multivitamins in healthy volunteers
127. The Effect of Lopinavir/Ritonavir and Darunavir/Ritonavir on the HIV Integrase Inhibitor S/GSK1349572 in Healthy Participants
128. Evaluation of the effect of UGT1A1 polymorphisms on the pharmacokinetics of oral and long-acting injectable cabotegravir
129. Serial Peripheral Blood Gene Expression Profiling to Assess Immune Quiescence in Kidney Transplant Recipients with Stable Renal Function
130. Long-Acting Cabotegravir and Rilpivirine for Maintenance of HIV-1 Suppression
131. Long-Acting Cabotegravir and Rilpivirine after Oral Induction for HIV-1 Infection
132. Pharmacokinetics and antiviral activity of cabotegravir and rilpivirine in cerebrospinal fluid following long-acting injectable administration in HIV-infected adults
133. 1687. High-Rates of Candida auris Carriage and Co-Colonization with Multidrug-Resistant Organisms (MDROs)
134. 2495. Pharmacokinetics of Cabotegravir (CAB) and Rilpivirine (RPV) Long-Acting (LA) Injectables in HIV-infected Individuals through 48 Weeks in the FLAIR and ATLAS Phase 3 Studies
135. Population Pharmacokinetic Analysis for Imipenem–Relebactam in Healthy Volunteers and Patients With Bacterial Infections
136. 2152. Detection of Uropathogens Using BD Kiestra™ Total Laboratory Automation with Urine Culture Application
137. 1532. Population Pharmacokinetic (PPK) Modeling and Simulation of Long-Acting (LA) Cabotegravir (CAB) to Inform Strategies Following Dosing Interruptions in HIV-1-Infected Subjects
138. Materials Employed for Breast Augmentation and Reconstruction
139. Randomized, double-blind, placebo-matched, multicenter trial of abacavir/lamivudine or tenofovir/emtricitabine with lopinavir/ritonavir for initial HIV treatment
140. Poster Board #-Session: P187-I 5 Year Follow Up of Paired Kidney Exchange at a Single Center.: Abstract# 844
141. Organization and expression of human telomere repeat binding factor genes
142. First large, multicenter, open-label study utilizing HLA-B*5701 screening for abacavir hypersensitivity in North America
143. Efficacy of Intracoronary Nicardipine in the Treatment of No-Reflow During Percutaneous Coronary Intervention
144. Overcoming the force and power of immunity: a history of immunosuppression in kidney transplantation
145. Coinjection strategy for visual identification of transgenic mice
146. Validation of a novel ELISA for measurement of MDA-LDL in human plasma
147. Facial Pain With Recurrent Facial Palsy
148. Soft Tissue Restoration Using Tissue Engineering
149. Pneumonia that recurs: your diagnostic challenge. (Cover Article)
150. Contributors
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.